Why are pharma prices changing?
Understanding the reasons behind medicines’ price changes has been a common challenge Prices of medicines evolve over time and are notoriously complex to understand at both…
By
Gustav Ando
Latest articles
All Articles
Rapid changes in the global IRP environment
The announcement on 25 October that the US is planning to introduce international reference pricing (IRP) on Medicare Part…
By
Nevermore ignore the role of digital health in health decision making
Here at the opening of the 23rd annual international meeting of ISPOR in Baltimore – 10 years after we started…
By
ISPOR 2018 Baltimore
We are pleased to announce that we will be at ISPOR 2018, 19-23 May, in Baltimore, Maryland. Please do…
By
Visit us at ISPOR 2017 Glasgow!
We are pleased to announce that we will be at the 20th Annual ISPOR European Congress, 4-8 November, in…
By
US Healthcare Reform: The ISPOR Debate
Much like the Pixies, who spent the last few days playing a series of concerts on their home turf…
By
Meet us at ISPOR Boston – Booth 204
Attending ISPOR in Boston? Stop by to see us at booth 204 – we have a lot of exciting…
By
Comparing health outcomes and pharma pricing around the world: A PISA for healthcare is a health minister’s worst nightmare…
Last week here in Paris, the OECD unveiled several ambitious healthcare policy initiatives at its Policy Forum and Health…
By
The Other vote today – Will the future of US drug pricing be decided? Will we see interstate parallel imports and interstate reference pricing?
For the global pharmaceutical industry, today marks a watershed moment that will have profound implications for its future. Clearly,…
By